Perspective: cancer vaccines in the era of immune checkpoint blockade

Tekijä Cebon, Jonathan
Julkaisussa Mamm Genome (2018)

Delayed Autoimmune Toxicity Occurring Several Months After Cessation of Anti‐PD‐1 Therapy

Tekijä Parakh, Sagun, Cebon, Jonathan, Klein, Oliver
Julkaisussa Oncologist (2018)

Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): a case report and review of the literature

Tekijä Gunjur, Ashray, Klein, Oliver, Kee, Damien, Cebon, Jonathan
Julkaisussa J Immunother Cancer (2019)

Effects of Epithelial to Mesenchymal Transition on T Cell Targeting of Melanoma Cells

Tekijä Woods, Katherine, Pasam, Anupama, Jayachandran, Aparna, Andrews, Miles C., Cebon, Jonathan
Julkaisussa Front Oncol (2014)

Embryonic Chicken Transplantation is a Promising Model for Studying the Invasive Behavior of Melanoma Cells

Tekijä Jayachandran, Aparna, McKeown, Sonja J., Woods, Briannyn L., Prithviraj, Prashanth, Cebon, Jonathan
Julkaisussa Front Oncol (2015)

A pilot study of intrahepatic yttrium‐90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver‐only metastases

Tekijä Arulananda, Surein, Parakh, Sagun, Palmer, Jodie, Goodwin, Mark, Andrews, Miles C., Cebon, Jonathan
Julkaisussa Cancer Rep (Hoboken) (2019)

The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populations

Tekijä Vella, Laura J, Andrews, Miles C, Pasam, Anupama, Woods, Katherine, Behren, Andreas, Cebon, Jonathan S
Julkaisussa Oncoimmunology (2014)

Characterising the phenotypic evolution of circulating tumour cells during treatment

Tekijä Tsao, Simon Chang-Hao, Wang, Jing, Wang, Yuling, Behren, Andreas, Cebon, Jonathan, Trau, Matt
Julkaisussa Nat Commun (2018)

Intercellular Resistance to BRAF Inhibition Can Be Mediated by Extracellular Vesicle–Associated PDGFRβ()

Tekijä Vella, Laura J., Behren, Andreas, Coleman, Bradley, Greening, David W., Hill, Andrew F., Cebon, Jonathan
Julkaisussa Neoplasia (2017)

A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma

Tekijä Ebert, Lisa M., MacRaild, Sarah E., Zanker, Damien, Davis, Ian D., Cebon, Jonathan, Chen, Weisan
Julkaistu 2012

Phosphoproteomic Analysis of Cell-Based Resistance to BRAF Inhibitor Therapy in Melanoma

Tekijä Parker, Robert, Vella, Laura J., Xavier, Dylan, Amirkhani, Ardeshir, Parker, Jimmy, Cebon, Jonathan, Molloy, Mark P.
Julkaisussa Front Oncol (2015)

Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations

Tekijä Chang-Hao Tsao, Simon, Weiss, Jonathan, Hudson, Christopher, Christophi, Christopher, Cebon, Jonathan, Behren, Andreas, Dobrovic, Alexander
Julkaisussa Sci Rep (2015)

Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma

Tekijä Woods, Katherine, Knights, Ashley J., Anaka, Matthew, Schittenhelm, Ralf B., Purcell, Anthony W., Behren, Andreas, Cebon, Jonathan
Julkaisussa J Immunother Cancer (2016)

Systems analysis identifies miR-29b regulation of invasiveness in melanoma

Tekijä Andrews, Miles C., Cursons, Joseph, Hurley, Daniel G., Anaka, Matthew, Cebon, Jonathan S., Behren, Andreas, Crampin, Edmund J.
Julkaisussa Mol Cancer (2016)

PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation

Tekijä Tutuka, Candani S. A., Andrews, Miles C., Mariadason, John M., Ioannidis, Paul, Hudson, Christopher, Cebon, Jonathan, Behren, Andreas
Julkaisussa Mol Cancer (2017)

Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion

Tekijä Prithviraj, Prashanth, Anaka, Matthew, McKeown, Sonja J, Permezel, Michael, Walkiewicz, Marzena, Cebon, Jonathan, Behren, Andreas, Jayachandran, Aparna
Julkaisussa Oncotarget (2015)

Alternate antigen processing in the presence of gamma interferon may misdirect the immune recognition of cancer

Tekijä Woods, Katherine, Schittenhelm, Ralf B, Heesterbeek, Dani, Knights, Ashley, Anaka, Matthew, Purcell, Anthony W, Behren, Andreas, Cebon, Jonathan
Julkaisussa J Immunother Cancer (2015)

Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy

Tekijä Prithviraj, Prashanth, McArthur, Grant, Atkinson, Victoria, Parente, Phillip, Andrews, Miles, Parakh, Sagun, Millward, Michael, Cebon, Jonathan, Klein, Oliver
Julkaisussa J Immunother Cancer (2015)

Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report

Tekijä Hultin, Sebastian, Nahar, Kazi, Menzies, Alexander M., Long, Georgina V., Fernando, Suran L., Atkinson, Victoria, Cebon, Jonathan, Wong, Muh Geot
Julkaisussa BMC Nephrol (2020)

Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors

Tekijä Anaka, Matthew, Hudson, Christopher, Lo, Pu-Han, Do, Hongdo, Caballero, Otavia L, Davis, Ian D, Dobrovic, Alexander, Cebon, Jonathan, Behren, Andreas
Julkaistu 2013